BIOMAT Database Logo BIOMAT Database Logo

A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2. 1977

R R Gorman, and F A Fitzpatrick, and O V Miller

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011449 Prostaglandin Endoperoxides Precursors in the biosynthesis of prostaglandins and thromboxanes from arachidonic acid. They are physiologically active compounds, having effect on vascular and airway smooth muscles, platelet aggregation, etc. Endoperoxides, Prostaglandin
D011463 Prostaglandins H A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.
D011465 Prostaglandins, Synthetic Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity. PG Analog,PG Analogs,Prostaglandin Analog,Prostaglandin Analogs,Prostaglandin Analogue,Synthetic Prostaglandin,Prostaglandin Analogues,Synthetic Prostaglandins,Analog, PG,Analog, Prostaglandin,Analogs, PG,Analogs, Prostaglandin,Analogue, Prostaglandin,Analogues, Prostaglandin,Prostaglandin, Synthetic
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D001095 Arachidonic Acids Eicosatetraenoic Acids,Acids, Arachidonic,Acids, Eicosatetraenoic

Related Publications

R R Gorman, and F A Fitzpatrick, and O V Miller
Imidazole: a selective inhibitor of thromboxane synthetase.
April 1977, Prostaglandins,
R R Gorman, and F A Fitzpatrick, and O V Miller
OKY-1581, a potential selective thromboxane synthetase inhibitor.
February 1981, European journal of pharmacology,
R R Gorman, and F A Fitzpatrick, and O V Miller
A selective inhibitor of thromboxane synthetase activity of rabbit heart tissue: a pyridazinic derivative.
August 1988, Prostaglandins, leukotrienes, and essential fatty acids,
R R Gorman, and F A Fitzpatrick, and O V Miller
CV-4151--a potent, selective thromboxane A2 synthetase inhibitor.
January 1986, Thrombosis research,
R R Gorman, and F A Fitzpatrick, and O V Miller
Selective thromboxane synthetase inhibitor and ischemic heart disease.
January 1984, Biomedica biochimica acta,
R R Gorman, and F A Fitzpatrick, and O V Miller
Selective inhibitor of thromboxane synthetase: pyridine and its derivatives.
January 1980, Advances in prostaglandin and thromboxane research,
R R Gorman, and F A Fitzpatrick, and O V Miller
Effect of selective thromboxane synthetase inhibitor on vein grafts.
November 1987, Southern medical journal,
R R Gorman, and F A Fitzpatrick, and O V Miller
Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
January 1983, Advances in prostaglandin, thromboxane, and leukotriene research,
R R Gorman, and F A Fitzpatrick, and O V Miller
9, 11-Azo-12-oxa-15-hydroxyprostanoic acid: a potent thromboxane synthetase inhibitor and a PGH2/TxA2 receptor antagonist.
November 1979, Prostaglandins and medicine,
R R Gorman, and F A Fitzpatrick, and O V Miller
Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
January 1983, Advances in prostaglandin, thromboxane, and leukotriene research,
Copied contents to your clipboard!